On August 8, 2012, the last long-term follow-up interview was conducted in our recently completed study of LSD-assisted psychotherapy for anxiety associated with advanced-stage illness in Switzerland. All twelve subjects have now completed the follow-up portion of this study, and the results are being prepared for publication. MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., is scheduled to visit Switzerland in September for the final monitoring visit.
